Articles

Other life sciences

Biotechnology of Switzerland: no way without small

The biotechnology industry of one of the world's leading pharmaceutical companies – Switzerland – is based on small innovative companies.

Biotechnology on lease

The effectiveness of leasing becomes obvious if the process of obtaining a certain resource is decomposed into components.

Bioethics

Prolonging youth

Aubrey de Grey claims that the average life expectancy of people in developed countries will soon grow to a thousand or more years, and by 2100 to 5000.

New in Gerontology

Laminopathies and the aging process

The problem of genetic control of life expectancy and the aging process has many facets, one of them was highlighted in the study of hereditary diseases included in the group of laminopathies.

Histocompatibility system genes and longevity

The study of genetic markers of aging and age-related diseases is one of the most relevant areas in gerontology.

Age-related changes in nonspecific immunity - prolonging life

Numerous facts indicate a decrease in the effectiveness of the functioning of the immune system with increasing age, as a result of which the incidence and mortality from infectious diseases increases tens and hundreds of times. The weakening and violation of the immune response is associated with an increase in the frequency of oncological and autoimmune diseases.

Business Angel for sliced DNA

To understand the revolutionary nature of the new technology, it is enough to give a simple example: to measure the concentration of an antibiotic in the blood by traditional methods, it will take two days, and the use of abnormal optical activity of DNA scraps turned into a liquid crystal will reduce this time to ten minutes.

The main scientific theories of aging

The mechanisms of aging are quite complex and diverse. Today there are several alternative theories that partly contradict each other, and partly complement each other.

Old and new theories of aging

There are several dozen theories of aging. Many of them are already only of historical interest, while the rest, reflecting a number of essential aspects of the process, can be put into a logical scheme of a more universal general mechanism of aging. One thing is common to all hypotheses – the aging of the body begins immediately after the division of the fertilized egg begins.

Nanotechnology

Biomedicine

Activation of protomitochondria is the path to cell rejuvenation

A curious research project is under consideration at the Eternal Youth Foundation. The data obtained by the author as a result of previous studies supported by the RFBR grant allow us to count on the development of ways to treat mitochondrial encephalomyopathies and slow down and even prevent the aging processes of cells induced by damage to their active oxygen forms by activating the growth of protomitochondria, as well as the elimination of old mitochondrial organelles – postmitochondria.

Biotechnology for Medicine (continued-3)

Natural habitat conditions sometimes demonstrate almost unique capabilities of animals to neutralize toxins or infections.

Stock market 2008 – "hot" five

Fortune magazine included GlaxoSmithKline, one of the world's largest pharmaceutical companies intensively engaged in the development and production of biotechnological drugs, and one Russian company in the top five in terms of investment attractiveness for next year: (true, it has nothing to do with biotech and biopharma):

Biotechnology for Medicine (continued-2)

Despite great success in the creation of synthetic medicines, today interest in the plant and animal world as a source of biologically active substances is constantly increasing.

How to make money on IPO expectations

The statistics of the Russian IPO market show that the shares of most companies fall in price after the initial public offering. Meanwhile, in the process of preparing for the IPO, issuers are restructuring, becoming transparent, and their value is growing rapidly. To participate in the growth that precedes the placement of shares, so-called pre-IPO funds are used.

Pharmaceutical industry: waiting for a deadlock

Competition from generic drugs (copies of original drugs) will lead to a reduction in sales of the largest American companies by $67 billion already in 2007-2012, as patent protection for more than 30 drugs will expire. This is almost half of the total revenue of US companies in 2007. Looking at all this, financial analysts do not recommend investing in the securities of pharmaceutical companies. Experts predict the leadership of biotechnologies, in which generics are technologically and legally impossible.